Citadel Advisors’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $53.1M | Buy |
|
|||||
|
2025
Q2 | $37.2M | Sell |
|
|||||
|
2025
Q1 | $48.4M | Buy |
|
|||||
|
2024
Q4 | $32.7M | Buy |
|
|||||
|
2024
Q3 | $31.6M | Buy |
|
|||||
|
2024
Q2 | $23.5M | Buy |
|
|||||
|
2024
Q1 | $8.21M | Sell |
|
|||||
|
2023
Q4 | $9.59M | Buy |
|
|||||
|
2023
Q3 | $2.84M | Buy |
|
|||||
|
2023
Q2 | $2.49M | Buy |
|
|||||
|
2023
Q1 | $14.6K | Buy |
|
|||||
|
2022
Q4 | $13K | Sell |
|
|||||
|
2022
Q3 | $284K | Sell |
|
|||||
|
2022
Q2 | $2.14M | Buy |
|
|||||
|
2022
Q1 | $224K | Sell |
|
|||||
|
2021
Q4 | $1.07M | Sell |
|
|||||
|
2021
Q3 | $1.07M | Sell |
|
|||||
|
2021
Q2 | $1.33M | Sell |
|
|||||
|
2021
Q1 | $1.78M | Sell |
|
|||||
|
2020
Q4 | $1.97M | Buy |
|
|||||
|
2020
Q3 | $905K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $365K | Buy |
|
|||||
|
2019
Q4 | $522K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $536K | Sell |
|
|||||
|
2019
Q1 | $829K | Sell |
|
|||||
|
2018
Q4 | $640K | Buy |
|
|||||
|
2018
Q3 | $542K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $285K | Sell |
|
|||||
|
2017
Q4 | $438K | Sell |
|
|||||
|
2017
Q3 | $435K | Sell |
|
|||||
|
2017
Q2 | $969K | Buy |
|
|||||
|
2017
Q1 | $206K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $936K | Buy |
|
|||||
|
2016
Q2 | $499K | Buy |
|
|||||
|
2016
Q1 | – | Hold |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $1M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $341K | Sell |
|
|||||
|
2014
Q4 | $348K | Sell |
|
|||||
|
2014
Q3 | $307K | Sell |
|
|||||
|
2014
Q2 | $599K | Buy |
|
|||||
|
2014
Q1 | $492K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $13K | Buy |
|